InvestorsHub Logo
Followers 11
Posts 1206
Boards Moderated 0
Alias Born 03/18/2015

Re: DadBod78 post# 126371

Saturday, 04/17/2021 7:21:01 PM

Saturday, April 17, 2021 7:21:01 PM

Post# of 140474
Vicarious has a concept and maybe a prototype at best. No clinical data no animal studies no IRCAD studies that they have shared. They have a nifty video/website and 1.2B valuation. That valuation is an awesome comp for Titan as Titan is ahead with more IP and a strategic partner in Medtronic. Market will figure this out eventually maybe at Medtronic milestone 3 or 4.

What would prevent ENOS from being VR capable if they want in a future generation? The VR is all hype and I’m sure it will have it own challenges with the FDA.

Vicarious appears likely to encounter IP issues should they attempt to commercialize. 4 patents sure seems pretty light at this point.